muramidase and plerixafor

muramidase has been researched along with plerixafor* in 2 studies

Other Studies

2 other study(ies) available for muramidase and plerixafor

ArticleYear
Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow.
    The Journal of experimental medicine, 2013, Oct-21, Volume: 210, Issue:11

    Blood neutrophil homeostasis is essential for successful host defense against invading pathogens. Circulating neutrophil counts are positively regulated by CXCR2 signaling and negatively regulated by the CXCR4-CXCL12 axis. In particular, G-CSF, a known CXCR2 signaler, and plerixafor, a CXCR4 antagonist, have both been shown to correct neutropenia in human patients. G-CSF directly induces neutrophil mobilization from the bone marrow (BM) into the blood, but the mechanisms underlying plerixafor-induced neutrophilia remain poorly defined. Using a combination of intravital multiphoton microscopy, genetically modified mice and novel in vivo homing assays, we demonstrate that G-CSF and plerixafor work through distinct mechanisms. In contrast to G-CSF, CXCR4 inhibition via plerixafor does not result in neutrophil mobilization from the BM. Instead, plerixafor augments the frequency of circulating neutrophils through their release from the marginated pool present in the lung, while simultaneously preventing neutrophil return to the BM. Our study demonstrates for the first time that drastic changes in blood neutrophils can originate from alternative reservoirs other than the BM, while implicating a role for CXCR4-CXCL12 interactions in regulating lung neutrophil margination. Collectively, our data provides valuable insights into the fundamental regulation of neutrophil homeostasis, which may lead to the development of improved treatment regimens for neutropenic patients.

    Topics: Animals; Benzylamines; Bone Marrow; Cell Movement; Cyclams; Granulocyte Colony-Stimulating Factor; Green Fluorescent Proteins; Heterocyclic Compounds; Humans; Leukocyte Count; Lung; Macaca fascicularis; Mice; Microscopy, Fluorescence, Multiphoton; Muramidase; Muscle, Skeletal; Mutation; Neutrophils; Pulmonary Circulation; Receptors, CXCR4; Receptors, Interleukin-8B

2013
Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Feb-15, Volume: 102, Issue:7

    The macrocyclic antiviral drug xylyl-bicyclam blocks entry of HIV into cells by targeting the CXCR4 coreceptor, a seven-helix transmembrane G-protein-coupled receptor. Its affinity for CXCR4 is enhanced by binding to Cu2+, Ni2+, or Zn2+. Metallocyclams have a rich configurational chemistry and proteins may bind selectively to specific metallocyclam configurations. Our studies of lysozyme reveal structural details of protein-metallocyclam interactions that are important for receptor recognition. Solution NMR studies show that Cu-cyclam interacts with specific tryptophan residues of lysozyme (Trp-62, Trp-63, and Trp-123). Two major binding sites for both Cu-cyclam and Cu2-xylyl-bicyclam were detected by x-ray crystallography. In the first site, Cu2+ in one cyclam ring of Cu2-xylyl-bicyclam adopts a trans configuration and is coordinated to a carboxylate oxygen of Asp-101, whereas for Cu-cyclam two ring NH groups form H bonds to the carboxylate oxygens of Asp-101, stabilizing an unusual cis (folded) cyclam configuration. For both complexes in this site, a cyclam ring is sandwiched between the indole side chains of two tryptophan residues (Trp-62 and Trp-63). In the second site, a trans cyclam ring is stacked on Trp-123 and H bonded to the backbone carbonyl of Gly-117. We show that there is a pocket in a model of the human CXCR4 coreceptor in which trans and cis configurations of metallobicyclam can bind by direct metal coordination to carboxylate side chains, cyclam-NH...carboxylate H bonding, together with hydrophobic interactions with tryptophan residues. These studies provide a structural basis for the design of macrocycles that bind stereospecifically to G-coupled and other protein receptors.

    Topics: Animals; Anti-HIV Agents; Benzylamines; Binding Sites; Chickens; Crystallography, X-Ray; Cyclams; Heterocyclic Compounds; Humans; In Vitro Techniques; Lactams, Macrocyclic; Metals; Models, Molecular; Muramidase; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Receptors, CXCR4

2005